Project Grant R21AI180945

Award Date 6/20/24
Completion Date 4/30/26
Dollars Obligated $447K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
The Project Grant award with ID R01AG090337 is funded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The total funding amount is $639,740.00 with a performance period from December 15, 2024 to November 30, 2029. The grant aims to explore the role of the CD38 enzyme and CD8 tissue resident memory (TRM) cells in the development of chronic lung fibrosis following viral pneumonia, including COVID-19. The research seeks to understand the...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) in the amount of $448,270 supports research on the role of alveolar type II (ATII) cell senescence in the pathogenesis of influenza in aging populations. The Ohio State University will conduct this 2-year research project aimed at defining the effects of aging, influenza virus infection, and a potential therapeutic treatment (CDP-choline) on ATII cell function, energy metabolism, and...
This federal Cooperative Agreement award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), will support a research project focused on understanding the mechanisms behind the poor clinical outcomes observed in older patients with severe respiratory viral infections, such as COVID-19. The $528,011 award, effective July 1, 2024 through April 30, 2029, will enable New York University School of Medicine to conduct a comprehensive investigation of host immune responses and...
This $693,942 National Institutes of Health National Heart Lung and Blood Institute Project Grant funds research at Northwestern University aimed at elucidating epigenetic modifiers of regulatory T cell function following viral pneumonia. The goal is to establish causal links between DNA methyltransferase activity, the DNMT adapter UHRF1, and DNA hypermethylation signatures in regulatory T cells during aging and their impaired reparative function after severe viral pneumonia. Through three...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $239,120 to Tufts University School of Medicine to conduct research on understanding the complex interplay between influenza virus infection and cell death responses in lung epithelial cells. The award aims to optimize a novel single-cell sequencing assay called scAnnexinV-seq to simultaneously measure the...
This $789,664 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a comprehensive study to characterize the effect of age on the cellular microenvironment of the human lung and peripheral blood. The Icahn School of Medicine at Mount Sinai will leverage single-cell RNA sequencing and spatial transcriptomics to model age-related changes in cell composition, gene expression, and cellular interactions. The goal is to uncover new therapeutic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $586,250 Project Grant (CFDA 93.855) to the University of Massachusetts Medical School to investigate how distinct age-associated B cell subsets can protect the aged from influenza. The project aims to determine the potential of different B cell subsets to respond to influenza infection and generate antibody-secreting cells, B cell memory, and long-lived antibody-secreting cells. Researchers will also compare the ability...
This $2,074,701 five-year federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a multidisciplinary research program at Emory University to study the biological and physical drivers of influenza A virus transmission in humans. The key objectives of the research are to: Define the dynamics of viral load, immune responses, and infectious aerosol production in humans...
This Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) provides $480,990 to the University of Illinois to investigate the role of aerocytes, a specialized capillary endothelial cell population, in regulating alveolar epithelial regeneration following lung injury. The research aims to establish aerocytes as central regulators of alveolar regeneration, with a focus on the signaling...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $910,000.00 to investigate the role of cellular senescence in severe COVID-19 illness associated with obesity and non-alcoholic steatohepatitis (NASH). The research aims to determine if removing senescent cells can alleviate severe COVID-19 symptoms in mouse models and human cell cultures derived from adipose...

A SPATIAL SEQUENCING ATLAS OF AGE-INDUCED CHANGES IN THE LUNG DURING INFLUENZA INFECTION - SUMMARY RESPIRATORY VIRAL INFECTION, SUCH AS SEASONAL FLU AND COVID PANDEMIC, HAS A SIGNIFICANT IMPACT ON GLOBAL HEALTH. INFLUENZA VIRUS EPIDEMICS RESULT IN SEVERE ILLNESS, HOSPITALIZATIONS, AND DEATHS, ESPECIALLY AMONG ELDERLY PEOPLE. AGING IS ASSOCIATED WITH A DECLINE IN IMMUNE FUNCTION, MAKING OLDER ADULTS MORE SUSCEPTIBLE TO SEVERE FLU SYMPTOMS AND COMPLICATIONS. UNDERSTANDING THE UNDERLYING MECHANISMS OF AGE-ASSOCIATED IMMUNE RESPONSES IN FLU IS CRUCIAL FOR DEVELOPING EFFECTIVE PREVENTION AND TREATMENT STRATEGIES. THE BASELINE INCREASE IN INFLAMMATION, OFTEN REFERRED TO AS INFLAMMAGING, IS A MAJOR DRIVER OF AGE-RELATED PATHOPHYSIOLOGICAL CHANGES. MURINE MODELS OF AGING HAVE BEEN SHOWN TO HAVE QUALITATIVELY AND QUANTITIVELY IMPAIRED ANTI-INFLUENZA IMMUNE RESPONSES: AGED LUNGS EXHIBIT ALTERED MYELOID CELL RECRUITMENT AND FUNCTION; LOWER TITERS OF NEUTRALIZING ANTIBODIES; AND DELAYED AND DIMINISHED RECRUITMENT OF CD4 AND CD8 T CELLS TO THE LUNG DURING INFECTION, WHICH RESULTS IN DELAYED VIRAL CLEARANCE. AGING ALTERS ALL ORGAN SYSTEMS, NOT JUST THE IMMUNE SYSTEM; AS SUCH, AGING MAY ALSO IMPACT THE HOST RESPONSE TO INFLUENZA A VIRUS (IAV) THROUGH DIRECT CHANGES IN LUNG TISSUE. NEVERTHELESS, LITTLE IS KNOWN ABOUT HOW IMMUNE CELLS INTERACT WITH EPITHELIAL AND ENDOTHELIAL CELLS IN THE LUNG AND HOW THESE INTERACTIONS CONTRIBUTE TO THE HOST DEFENSE, TISSUE INJURY, WOUND HEALING IN THE LUNG AND COAGULOPATHY SYSTEMICALLY WITH AGING. PREVIOUSLY PUBLISHED RESEARCH FROM THE TEAM AND OTHERS DEMONSTRATE THAT AGED IMMUNE CELLS DRIVE A SENESCENT PHENOTYPE IN NON-IMMUNE TISSUES, AND THAT A SUBSET OF TYPE 2 INNATE LYMPHOID CELLS (ILC2S) PROMOTES WOUND HEALING AND TISSUE REPAIR IN THE LUNG FOLLOWING IAV INFECTION. THESE OBSERVATIONS HIGHLIGHT THE IMPORTANCE OF CROSSTALK AMONG IMMUNE, EPITHELIAL, AND ENDOTHELIAL CELLS DURING INFECTION, WHICH ALSO DEMAND NEW METHODOLOGY TO MORE COMPREHENSIVELY INVESTIGATE THE COLOCALIZATION OF THESE CELLULAR COMPONENTS. NEW SPATIAL SEQUENCING TECHNIQUES, SUCH AS THE 10X GENOMICS VISIUM PLATFORM, OFFER THE ABILITY TO IDENTIFY CELLS AND THEIR GENE EXPRESSION PROFILES IN SITU AT A RESOLUTION NOT PREVIOUSLY POSSIBLE, PARTICULARLY WHEN PAIRED WITH SCRNA-SEQ. THEREFORE, THE TEAM SEEK TO UTILIZE A COMBINATION OF SCRNA-SEQ, SPATIAL SEQUENCING, AND BULK RNA- SEQ TO GENERATE A MULTIFACETED, HIGH-RESOLUTION ATLAS OF YOUNG AND AGED LUNG TISSUE FOLLOWING INFLUENZA INFECTION AND IDENTIFY KEY CHANGES INDUCED BY AGING IN THIS CLINICALLY RELEVANT SETTING IN THIS PROPOSED STUDY. USING ADVANCED COMPUTATIONAL ALGORITHMS, THE TEAM WILL FURTHER DELINEATE HOW LUNG EPITHELIAL CELLS AFFECT THE MIGRATION AND TISSUE RETENTION OF IMMUNE CELLS, HOW IMMUNE CELLS TRIGGER TISSUE REPAIR AND ENDOTHELIAL CELL ACTIVATION AND COAGULATION, AND HOW NOVEL MOLECULAR PATHWAYS AFFECT INFLAMMATION AND FIBROSIS IN THE RESOLUTION PHASE OF INFECTION IN THE PROPOSED STUDY. OVERALL, THE TEAM ANTICIPATE THAT OUR PROJECT WILL IDENTIFY POTENTIAL TARGETS FOR THE DEVELOPMENT OF NEW THERAPEUTIC STRATEGIES TO PREVENT AND TREAT SEVERE FLU SYMPTOMS IN ELDERLY PEOPLE.

Posted 6/20/24, 12:00 AM